-trisomy 21: 1,5/1000; other unbalanced autosomal disorders: 0,5/ 1000; -balanced chromosomal disorders with a normal phenotype 2/1000 -among 1000 known pregnancies 150 will abort spontaneously: among them 100 have an abnormal chromosomal complement: 20 Turner syndrome, 20 trisomies 16 and 20 triploidies (more than 10% of each of those 3 syndromes are found among the spontaneous miscarriages); those figures exclude the undetected very early foetal losses (only one out of 2 conceptions would come to term). -Humans would have the highest rate of abnormal gametes. 
I-2. Etiology

I-2.3 Environmental factors
Ovulation induction, ionizing radiations, antimitotic agents.
II-Karyotype indications
II-1. Synopsis
II-1.1. Karyotype
The karyotype is the study of the individual chromosomal complement through which one can detect chromosomal rearrangements constitutional or acquired on at least one band equivalent to 10 3 to 10 4 K bases; since the scale is not at the gene level the karyotpe is useless in monogenic diseases (except in research). 10% of children with a congenital defect would have a chromosomal anomaly. Karyotype can be done on peripheral lymphocytes, tumour cells (bone marrow) fibroblasts, gametes, amniocytes or trophoblasts upon indications. A mitogen stimulates cell growth (lymphocytes), mitoses are blocked in metaphase by a spindle poison, a hypotonic solution will disperse the chromosomes and the banding techniques will reveal a number of successive bands on each chromosome. 
II-1.2. Fluorescent in situ hybridization (FISH)
II-2.2. during childhood and adolescence if
Psycho motor retardation (fra X, Klinefelter). Dysmorphism with visceral anomalies undetected during infancy. Unexplained short stature (Turner). Hypogonadism (Klinefelter, Turner).
II-2.3. during adulthood
Parents of a child with a chromosomal disorder. Sterility workup once gynaecological or endocrine causes have been ruled out (Klinefelter, Turner, Testicular feminization). If more than two spontaneous miscarriages cytogenetic studies are indicated on the parents to rule out a translocation carrier; a foetal karyotype is recommended if at all possible. 
II-2.4. during pregnancy
